UnitedHealth Group (NYSE: UNH) Soars on Strong Q1 Earnings and Raised Outlook

Font: Financial Modeling Prep  • Apr 21, 2026

• UnitedHealth Group (NYSE: UNH) reported robust first-quarter earnings, surpassing Wall Street's expectations for both adjusted earnings per share and revenue.
• The company demonstrated improved operational efficiency, evidenced by a better medical care ratio (MCR) of 83.9%, indicating effective cost management.
• Following the strong performance, UnitedHealth Group raised its full-year 2026 profit outlook to over $18.25 per share, leading to an over 8% surge in its stock price.

UnitedHealth Group (NYSE: UNH) is a major American health insurance and services provider. The company operates through two main divisions: UnitedHealthcare, which offers insurance coverage, and Optum, which provides health services and technology. Its performance often influences the broader managed care sector, including competitors like Humana (NYSE: HUM).

On April 21, 2026, investment firm Evercore ISI reiterates its "Outperform" rating for UnitedHealth Group. The firm also raises its price target for the company's stock to $400 from a previous target of $350. This update reflects a positive view of the company's financial health and future prospects.

This confidence follows a strong first-quarter earnings report. As highlighted by Benzinga, UnitedHealth Group delivers adjusted earnings per share of $7.23 on revenue of $111.70 billion. These results are significantly higher than the Wall Street consensus estimates of $6.58 in earnings and $109.58 billion in revenue.

A key driver for the strong results is better cost management. This is visible in the company's medical care ratio (MCR), which improves to 83.9%. The MCR measures how much of premium income is spent on medical claims, so a lower percentage suggests greater efficiency and profitability.

Following the strong quarter, UnitedHealth Group raises its full-year 2026 profit outlook to over $18.25 per share. As highlighted by 24/7 Wall St., the positive news causes the company's stock to surge more than 8%, lifting the stock of competitor Humana as well.